Rituximab-Induced Interstitial Pneumonia due to CD8-Positive T Cell Infiltration

Publisher： Karger

E-ISSN： 1421-9662|128|2|107-109

ISSN： 0001-5792

Source： Acta Haematologica, Vol.128, Iss.2, 2012-06, pp. : 107-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Direct and Indirect Rituximab‐Induced T Cell Depletion: Comment on the Article by Mélet et al

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 4, 2014-04 ,pp. : 1053-1053

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk Factors for Rituximab-Induced Interstitial Lung Diseases in Patients with Malignant Lymphoma

By  

Respiration, Vol. 85, Iss. 2, 2012-12 ,pp. : 175-175

Karger

Access to resources Recommend Favorite

Rituximab-Induced Hypersensitivity Pneumonitis

By  

Respiration, Vol. 78, Iss. 2, 2008-10 ,pp. : 225-229

Karger

Access to resources Recommend Favorite

CD8‐positive peripheral T‐cell lymphoma with aberrant expression of CD20 and concurrent in situ follicular lymphoma

By  

JOURNAL OF CUTANEOUS PATHOLOGY, Vol. 42, Iss. 1, 2015-01 ,pp. : 66-72

John Wiley & Sons Inc

Access to resources Recommend Favorite

TNF‐α antagonist may not be suitable for severe rituximab‐induced interstitial lung disease

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 3, 2015-06 ,pp. : 249-250

John Wiley & Sons Inc

Access to resources Recommend Favorite